ipca laboratories uk limited

Live MatureMidHealthy

ipca laboratories uk limited Company Information

Share IPCA LABORATORIES UK LIMITED

Company Number

04951981

Shareholders

ipca laboratories limited

ipca laboratories ltd

Group Structure

View All

Industry

Manufacture of pharmaceutical preparations

 

Registered Address

units 97-98 silverbriar, sunderland enterprise park east, sunderland, SR5 2TQ

ipca laboratories uk limited Estimated Valuation

£12.7m

Pomanda estimates the enterprise value of IPCA LABORATORIES UK LIMITED at £12.7m based on a Turnover of £11.8m and 1.08x industry multiple (adjusted for size and gross margin).

ipca laboratories uk limited Estimated Valuation

£2m

Pomanda estimates the enterprise value of IPCA LABORATORIES UK LIMITED at £2m based on an EBITDA of £453.5k and a 4.47x industry multiple (adjusted for size and gross margin).

ipca laboratories uk limited Estimated Valuation

£17.6m

Pomanda estimates the enterprise value of IPCA LABORATORIES UK LIMITED at £17.6m based on Net Assets of £8.5m and 2.07x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Ipca Laboratories Uk Limited Overview

Ipca Laboratories Uk Limited is a live company located in sunderland, SR5 2TQ with a Companies House number of 04951981. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in November 2003, it's largest shareholder is ipca laboratories limited with a 68.6% stake. Ipca Laboratories Uk Limited is a mature, mid sized company, Pomanda has estimated its turnover at £11.8m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Ipca Laboratories Uk Limited Health Check

Pomanda's financial health check has awarded Ipca Laboratories Uk Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

2 Strong

positive_score

4 Regular

positive_score

6 Weak

size

Size

annual sales of £11.8m, make it smaller than the average company (£38.3m)

£11.8m - Ipca Laboratories Uk Limited

£38.3m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 5%, show it is growing at a similar rate (4.8%)

5% - Ipca Laboratories Uk Limited

4.8% - Industry AVG

production

Production

with a gross margin of 10.2%, this company has a higher cost of product (30.9%)

10.2% - Ipca Laboratories Uk Limited

30.9% - Industry AVG

profitability

Profitability

an operating margin of 3.8% make it less profitable than the average company (7.7%)

3.8% - Ipca Laboratories Uk Limited

7.7% - Industry AVG

employees

Employees

with 6 employees, this is below the industry average (93)

6 - Ipca Laboratories Uk Limited

93 - Industry AVG

paystructure

Pay Structure

on an average salary of £63k, the company has an equivalent pay structure (£65.3k)

£63k - Ipca Laboratories Uk Limited

£65.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £2m, this is more efficient (£386.2k)

£2m - Ipca Laboratories Uk Limited

£386.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 102 days, this is later than average (50 days)

102 days - Ipca Laboratories Uk Limited

50 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 175 days, this is slower than average (34 days)

175 days - Ipca Laboratories Uk Limited

34 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 170 days, this is more than average (117 days)

170 days - Ipca Laboratories Uk Limited

117 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 9 weeks, this is average cash available to meet short term requirements (8 weeks)

9 weeks - Ipca Laboratories Uk Limited

8 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 40.6%, this is a similar level of debt than the average (45%)

40.6% - Ipca Laboratories Uk Limited

45% - Industry AVG

IPCA LABORATORIES UK LIMITED financials

EXPORTms excel logo

Ipca Laboratories Uk Limited's latest turnover from March 2024 is £11.8 million and the company has net assets of £8.5 million. According to their latest financial statements, Ipca Laboratories Uk Limited has 6 employees and maintains cash reserves of £1 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover11,807,4527,015,52114,857,93610,177,395656,9091,007,984024,453317,1302,619,3501,867,0911,798,5571,008,900225,793208,513
Other Income Or Grants000000000000000
Cost Of Sales10,608,8096,870,5168,044,1174,556,011417,547598,517013,836188,2171,665,0871,198,4101,129,308671,470148,853139,654
Gross Profit1,198,643145,0056,813,8195,621,384239,362409,468010,617128,914954,263668,681669,249337,43076,94068,859
Admin Expenses750,876736,0184,040,0733,481,002-47,245-819,706-2,135,493-599,767-6,325637,560785,383702,811452,822110,532388,070
Operating Profit447,767-591,0132,773,7462,140,382286,6071,229,1742,135,493610,384135,239316,703-116,702-33,562-115,392-33,592-319,211
Interest Payable000800014,062144,624130,00000000
Interest Receivable001,4762171613810545908856214343377219
Pre-Tax Profit1,447,767-91,0132,775,2222,140,591286,6221,229,3122,135,598596,366-9,295186,791-116,646-33,348-115,049-33,215-318,992
Tax00-567,802-431,546-54,458-233,569-405,764-119,2730-39,22600000
Profit After Tax1,447,767-91,0132,207,4201,709,045232,164995,7431,729,834477,093-9,295147,565-116,646-33,348-115,049-33,215-318,992
Dividends Paid000000000000000
Retained Profit1,447,767-91,0132,207,4201,709,045232,164995,7431,729,834477,093-9,295147,565-116,646-33,348-115,049-33,215-318,992
Employee Costs378,000336,2443,779,8343,001,059165,951168,547049,09886,020457,622345,287319,382157,74243,10841,530
Number Of Employees669272330121188411
EBITDA*453,459-590,5443,501,6442,600,091515,1661,457,7342,364,053841,943360,858475,970-14,57676,7593,45646,278-274,914

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets22,8551,4054,013,6872,374,96400000000222
Intangible Assets00002228,561457,121685,681917,2401,142,859159,326261,452371,773219,62559,859
Investments & Other4,892,7514,892,751720,935720,9354,892,7514,892,7514,892,7514,892,7514,892,7514,893,7754,893,7754,893,7753,863,95500
Debtors (Due After 1 year)000000000000000
Total Fixed Assets4,915,6064,894,1564,734,6223,095,8994,892,7535,121,3125,349,8725,578,4325,809,9916,036,6345,053,1015,155,2274,235,730219,62759,861
Stock & work in progress4,947,2082,411,3251,544,481890,34000000000000
Trade Debtors3,319,7562,374,1653,399,9671,717,3670004,00048,000288,000391,635478,621228,93537,47647,825
Group Debtors000000000000000
Misc Debtors44,236522,424226,122188,8755,3041,9451,93900000000
Cash1,043,130147,8522,006,5893,334,00112,15918,87518,02223,87911,75824,42110,71111,70074,05963,01987,793
misc current assets0000000000001,029,82000
total current assets9,354,3305,455,7667,177,1596,130,58317,46320,82019,96127,87959,758312,421402,346490,3211,332,814100,495135,618
total assets14,269,93610,349,92211,911,7819,226,4824,910,2165,142,1325,369,8335,606,3115,869,7496,349,0555,455,4475,645,5485,568,544320,122195,479
Bank overdraft000000000000000
Bank loan000000000000000
Trade Creditors 5,092,9022,989,6061,302,8601,133,76831,8240000758,6632,5004,16558,81326,37413,516
Group/Directors Accounts0000000942,824934,667000000
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities693,334324,383927,049706,6708,3524,2562,70026,18849,892000000
total current liabilities5,786,2363,313,9892,229,9091,840,43840,1764,2562,700969,012984,559758,6632,5004,16558,81326,37413,516
loans00000000449,9844,000,00000000
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities0000000001,145,8915,156,0115,227,8015,062,80100
provisions00411,127322,71900000000000
total long term liabilities00411,127322,7190000449,9845,145,8915,156,0115,227,8015,062,80100
total liabilities5,786,2363,313,9892,641,0362,163,15740,1764,2562,700969,0121,434,5435,904,5545,158,5115,231,9665,121,61426,37413,516
net assets8,483,7007,035,9339,270,7457,063,3254,870,0405,137,8765,367,1334,637,2994,435,206444,501296,936413,582446,930293,748181,963
total shareholders funds8,483,7007,035,9339,270,7457,063,3254,870,0405,137,8765,367,1334,637,2994,435,206444,501296,936413,582446,930293,748181,963
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit447,767-591,0132,773,7462,140,382286,6071,229,1742,135,493610,384135,239316,703-116,702-33,562-115,392-33,592-319,211
Depreciation5,692469727,898459,70900000000002,110
Amortisation0000228,559228,560228,560231,559225,619159,267102,126110,321118,84879,87042,187
Tax00-567,802-431,546-54,458-233,569-405,764-119,2730-39,22600000
Stock2,535,883866,844654,141890,34000000000000
Debtors467,403-729,5001,719,8471,900,9383,3596-2,061-44,000-240,000-103,635-86,986249,686191,459-10,34947,825
Creditors2,103,2961,686,746169,0921,101,94431,824000-758,663756,163-1,665-54,64832,43912,85813,516
Accruals and Deferred Income368,951-602,666220,379698,3184,0961,556-23,488-23,70449,892000000
Deferred Taxes & Provisions0-411,12788,408322,71900000000000
Cash flow from operations-77,580-54,9351,037,7331,500,248493,2691,225,7151,936,862742,966-107,9131,296,54270,745-227,575-155,56469,485-309,223
Investing Activities
capital expenditure000000000-1,142,80002-270,996-239,636-104,158
Change in Investments04,171,8160-4,171,8160000-1,024001,029,8203,863,95500
cash flow from investments0-4,171,81604,171,81600001,024-1,142,8000-1,029,818-4,134,951-239,636-104,158
Financing Activities
Bank loans000000000000000
Group/Directors Accounts000000-942,8248,157934,667000000
Other Short Term Loans 000000000000000
Long term loans0000000-449,984-3,550,0164,000,00000000
Hire Purchase and Lease Commitments000000000000000
other long term liabilities00000000-1,145,891-4,010,120-71,790165,0005,062,80100
share issue0-2,143,7990484,240-500,000-1,225,000-1,000,000-275,0004,000,000000268,231145,000500,955
interest001,47620916138105-14,017-144,534-129,91256214343377219
cash flow from financing0-2,143,7991,476484,449-499,984-1,224,862-1,942,719-730,84494,226-140,032-71,734165,2145,331,375145,377501,174
cash and cash equivalents
cash895,278-1,858,737-1,327,4123,321,842-6,716853-5,85712,121-12,66313,710-989-62,35911,040-24,77487,793
overdraft000000000000000
change in cash895,278-1,858,737-1,327,4123,321,842-6,716853-5,85712,121-12,66313,710-989-62,35911,040-24,77487,793

ipca laboratories uk limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for ipca laboratories uk limited. Get real-time insights into ipca laboratories uk limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Ipca Laboratories Uk Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for ipca laboratories uk limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in SR5 area or any other competitors across 12 key performance metrics.

ipca laboratories uk limited Ownership

IPCA LABORATORIES UK LIMITED group structure

Ipca Laboratories Uk Limited has no subsidiary companies.

Ultimate parent company

IPCA LABORATORIES LTD

#0036185

1 parent

IPCA LABORATORIES UK LIMITED

04951981

IPCA LABORATORIES UK LIMITED Shareholders

ipca laboratories limited 68.63%
ipca laboratories ltd 31.37%

ipca laboratories uk limited directors

Ipca Laboratories Uk Limited currently has 2 directors. The longest serving directors include Dr Derek Londesbrough (Aug 2017) and Mr Manish Jain (Aug 2017).

officercountryagestartendrole
Dr Derek Londesbrough54 years Aug 2017- Director
Mr Manish Jain50 years Aug 2017- Director

P&L

March 2024

turnover

11.8m

+68%

operating profit

447.8k

-176%

gross margin

10.2%

+391.15%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

8.5m

+0.21%

total assets

14.3m

+0.38%

cash

1m

+6.06%

net assets

Total assets minus all liabilities

ipca laboratories uk limited company details

company number

04951981

Type

Private limited with Share Capital

industry

21200 - Manufacture of pharmaceutical preparations

incorporation date

November 2003

age

22

incorporated

UK

ultimate parent company

IPCA LABORATORIES LTD

accounts

Full Accounts

last accounts submitted

March 2024

previous names

N/A

accountant

-

auditor

LEESING MARRISON LEE LIMITED

address

units 97-98 silverbriar, sunderland enterprise park east, sunderland, SR5 2TQ

Bank

-

Legal Advisor

-

ipca laboratories uk limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to ipca laboratories uk limited.

ipca laboratories uk limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for IPCA LABORATORIES UK LIMITED. This can take several minutes, an email will notify you when this has completed.

ipca laboratories uk limited Companies House Filings - See Documents

datedescriptionview/download